These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9128352)

  • 1. Resolution of AIDS associated cryptosporidiosis after treatment with indinavir.
    Grube H; Ramratnam B; Ley C; Flanigan TP
    Am J Gastroenterol; 1997 Apr; 92(4):726. PubMed ID: 9128352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cryptosporidium infection: value of a protease inhibitor].
    Contamin B; Boibieux A; Gérard-Boncompain M; Bouhour D; Girault V; Biron F; Peyramond D
    Presse Med; 1997 Mar; 26(9):416. PubMed ID: 9137399
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.
    Blum L; Pellet C; Agbalika F; Blanchard G; Morel P; Calvo F; Lebbé C
    AIDS; 1997 Nov; 11(13):1653-5. PubMed ID: 9365774
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.
    Carr A; Marriott D; Field A; Vasak E; Cooper DA
    Lancet; 1998 Jan; 351(9098):256-61. PubMed ID: 9457096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy.
    Goguel J; Katlama C; Sarfati C; Maslo C; Leport C; Molina JM
    AIDS; 1997 Nov; 11(13):1658-9. PubMed ID: 9365777
    [No Abstract]   [Full Text] [Related]  

  • 7. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models.
    Mele R; Gomez Morales MA; Tosini F; Pozio E
    Int J Parasitol; 2003 Jul; 33(7):757-64. PubMed ID: 12814654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin.
    Palmieri F; Cicalini S; Froio N; Rizzi EB; Goletti D; Festa A; Macrí G; Petrosillo N
    Int J STD AIDS; 2005 Jul; 16(7):515-7. PubMed ID: 16004637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The loading of labelled antibody-engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum.
    Bondioli L; Ludovisi A; Tosi G; Ruozi B; Forni F; Pozio E; Vandelli MA; Gómez-Morales MA
    Parasitology; 2011 Sep; 138(11):1384-91. PubMed ID: 21819637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of antiproteases in the treatment of microsporidia and/or cryptosporidia infections in HIV-seropositive patients].
    Bobin S; Bouhour D; Durupt S; Boibieux A; Girault V; Peyramond D
    Pathol Biol (Paris); 1998 Jun; 46(6):418-9. PubMed ID: 9769873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of paromomycin sulfate (Humagel) in an AIDS infected patient with intestinal cryptosporidiosis].
    Hammel P; Rogeaux O; Diouf ML; Gouyon B; Ruszniewski P; Bernades P
    Gastroenterol Clin Biol; 1992; 16(12):1010-1. PubMed ID: 1493891
    [No Abstract]   [Full Text] [Related]  

  • 13. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor.
    Murphy M; Armstrong D; Sepkowitz KA; Ahkami RN; Myskowski PL
    AIDS; 1997 Feb; 11(2):261-2. PubMed ID: 9030382
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Dugue GA
    J Antimicrob Chemother; 2004 Feb; 53(2):403; author reply 403. PubMed ID: 14729752
    [No Abstract]   [Full Text] [Related]  

  • 15. [A comparative study of indinavir versus ritonavir for assessing the development of opportunistic diseases in adult AIDS patients].
    Disdier OM; Pérez CM; Suárez E
    Bol Asoc Med P R; 1999; 91(7-12):85-90. PubMed ID: 10842439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy.
    Foudraine NA; Weverling GJ; van Gool T; Roos MT; de Wolf F; Koopmans PP; van den Broek PJ; Meenhorst PL; van Leeuwen R; Lange JM; Reiss P
    AIDS; 1998 Jan; 12(1):35-41. PubMed ID: 9456253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
    AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete regression of AIDS-related Kaposi's sarcoma-associated human herpesvirus-8 during therapy with indinavir.
    Martinelli C; Zazzi M; Ambu S; Bartolozzi D; Corsi P; Leoncini F
    AIDS; 1998 Sep; 12(13):1717-9. PubMed ID: 9764794
    [No Abstract]   [Full Text] [Related]  

  • 19. Intestinal cryptosporidiosis as an initial manifestation in a previously healthy Japanese patient with AIDS.
    Fujikawa H; Miyakawa H; Iguchi K; Nishizawa M; Moro K; Nagai K; Ishibashi M
    J Gastroenterol; 2002; 37(10):840-3. PubMed ID: 12424568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
    Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
    AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.